U.S. Telemedicine Market Size, Share & Analysis Report, 2023-2032
The U.S. telemedicine market size was exhibited at USD 35.19 billion in 2022 and is projected to hit around USD 118.4 billion by 2032, growing at a CAGR of 12.9% during the forecast period 2023 to 2032.
Key Pointers:
Report Scope of the U.S. Telemedicine Market
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 39.73 Billion |
|
Market Size by 2032 |
USD 118.4 Billion |
|
Growth Rate from 2023 to 2032 |
CAGR of 12.9% |
|
Base Year |
2022 |
|
Forecast Period |
2023 to 2032 |
|
Segments Covered |
Service, Type, Specialty, Component, Delivery Mode |
The increasing prevalence of chronic diseases is anticipated to foster market growth. A strong prevalence of these illnesses, such as cancer, diabetes, and heart diseases, among others, due to the higher adoption of unhealthy habits and sedentary lifestyles viz., consuming alcohol and smoking cigarettes is accelerating the telemedicine industry penetration in the U.S.
Moreover, favorable government initiatives towards the improvement of healthcare systems are also escalating the demand for telemedicine in the region. For instance, in March 2020, the Health Insurance Portability and Accountability Act's policies were made public by the Centers for Medicare & Medicaid Services Administrator (HIPAA). According to this policy, patients are entitled to contact any doctor throughout the pandemic using their smartphones and platforms. Such regulatory changes have increased the use of telemedicine, which is foreseen to boost market expansion.
Security risks over confidential patient data may limit industry expansion. Platforms, including electronic prescriptions, electronic health records, and fitness or medical applications, among others, must be integrated into telemedicine systems. Data breaches give unauthorized access to private data, including medical records, personal information, prescription information, insurance IDs, and addresses. Therefore, data threats and breaches associated with telemedicine services are impeding market expansion. Nevertheless, ongoing technological advancements are likely to aid in combatting these issues.
Based on service, the U.S. telemedicine market is segmented into tele-consulting, tele-education/training, tele-monitoring, and others. The tele-education/training segment is poised to depict over 14.9% CAGR from 2023 to 2032. Healthcare professionals that work in remote or rural areas can receive their education through tele-education. It removes constraints caused by distance and enhances medical education/training services, particularly in rural areas. Additionally, tele-educational services support emergency medical care, while improving overall treatment outcomes.
In terms of type, the U.S. telemedicine market is categorized into telehospital and telehome. The telehospital segment was valued at more than USD 22.19 billion in 2022. Telehospital is further segregated into academic hospitals, big independent hospitals, medium independent hospitals, little independent hospitals, and so on. Telehospital services demand is driven by the requirement for remote patient monitoring. Additionally, the growing need for affordable, high-quality healthcare services is a key factor aiding segment expansion.
With respect to specialty, the U.S. telemedicine market is divided into cardiology, neurology, gynecology, orthopedics, mental health, dermatology, critical care, and neonatology. U.S. market from the gynecology segment is foreseen to surpass USD 4.9 billion by 2032. The segment growth is attributable to the widespread application of telemedicine in gynecology such as for preconception counseling, family planning including contraception & medical abortion, teleradiology, infertility workup, cervical cancer screening, and colposcopy, among others. It enables early access to schedule optimization for high-risk obstetrics and medical abortion services, which is estimated to facilitate segment progress.
Based on components, the U.S. telemedicine market is classified into hardware, software, and service. The software segment is primed to reach more than USD 37.15 billion by 2032. Numerous businesses are releasing user-friendly telemedicine platforms and creative mobile applications. Additionally, it is anticipated that over the analysis period, the demand for telemedicine software is expected to rise in line with the demand for virtual visits, thereby benefitting the segment.
Some of the prominent players in the U.S. Telemedicine Market include:
Segments Covered in the Report
This report forecasts the volume and revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor has segmented the U.S. Telemedicine market.
By Service
By Type
By Specialty
By Component
By Delivery Mode
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definition
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Unpaid sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 U.S. telemedicine industry 3600 synopsis, 2020 - 2032
2.1.1 Business trends
Chapter 3 US Telemedicine Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2020 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases
3.3.1.2 Growing number of smartphone users
3.3.1.3 Technological advancements related to mobile phones and internet
3.3.1.4 Long waiting time in hospitals for disease treatment
3.3.1.5 Favorable government initiatives
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security and privacy concerns
3.3.2.2 Stringent regulatory policies and limited reimbursement in the U.S.
3.4 Growth potential analysis
3.4.1 By service
3.4.2 By type
3.4.3 By specialty
3.4.4 By component
3.4.5 By delivery mode
3.5 COVID-19 impact analysis
3.6 Penetration/adoption in U.S. hospitals
3.7 Reimbursement scenario in U.S.
3.8 Telemedicine modalities
3.9 Government initiatives
3.9.1 U.S. Department of Agriculture (USDA) Initiative
3.9.2 Rural Health Care (RHC) Program
3.9.3 U.S. Department of Defense Initiative
3.10 Telemedicine future trends
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Competitive analysis of major players
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 US Telemedicine Market, By Service
5.1 Key segment trends
5.2 Tele-consulting
5.2.1 Market size, 2020 – 2032
5.3 Tele-monitoring
5.3.1 Market size, 2020 – 2032
5.4 Tele-education/training
5.4.1 Market size, 2020 – 2032
5.5 Others
5.5.1 Market size, 2020 – 2032
Chapter 6 US Telemedicine Market, By Type
6.1 Key segment trends
6.2 Telehospital
6.2.1 Market size, 2020 – 2032
6.2.2 Integrated delivery network (IDN)
6.2.2.1 Market size, 2020 – 2032
6.2.3 Academic medical center (AMC)
6.2.3.1 Market size, 2020 – 2032
6.2.4 Large independent hospitals
6.2.4.1 Market size, 2020 – 2032
6.2.5 Medium independent hospitals
6.2.5.1 Market size, 2020 – 2032
6.2.6 Small hospitals
6.2.6.1 Market size, 2020 – 2032
6.2.7 Others
6.2.7.1 Market size, 2020 – 2032
6.3 Telehome
6.3.1 Market size, 2020 – 2032
Chapter 7 US Telemedicine Market, By Specialty
7.1 Key segment trends
7.2 Cardiology
7.2.1 Market size, 2020 – 2032
7.3 Gynecology
7.3.1 Market size, 2020 – 2032
7.4 Neurology
7.4.1 Market size, 2020 – 2032
7.5 Orthopedics
7.5.1 Market size, 2020 – 2032
7.6 Dermatology
7.6.1 Market size, 2020 – 2032
7.7 Metal health
7.7.1 Market size, 2020 – 2032
7.8 Critical care
7.8.1 Market size, 2020 – 2032
7.9 Neonatology
7.9.1 Market size, 2020 – 2032
7.10 Others
7.10.1 Market size, 2020 – 2032
Chapter 8 US Telemedicine Market, By Component
8.1 Key segment trends
8.2 Hardware
8.2.1 Market size, 2020 – 2032
8.3 Software
8.3.1 Market size, 2020 – 2032
8.4 Services
8.4.1 Market size, 2020 – 2032
Chapter 9 US Telemedicine Market, By Delivery Mode
9.1 Key segment trends
9.2 Web/Mobile
9.2.1 Market size, 2020 – 2032
9.2.2 Telephonic
9.2.2.1 Market size, 2020 – 2032
9.2.3 Visualized
9.2.3.1 Market size, 2020 – 2032
9.3 Call Centers
9.3.1 Market size, 2020 – 2032
Chapter 10 Company Profiles
10.1 Allscripts Healthcare Solutions Inc
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Product landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 AMD Global Telemedicine, Inc.
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 American Well
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 Strategic outlook
10.3.5 SWOT analysis
10.4 Oracle Corporation (Cerner)
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 Cisco
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Eagle Telemedicine
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 Honeywell International Inc.
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 Koninklijke Philips N.V.
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 Strategic outlook
10.8.5 SWOT analysis
10.9 McKesson Corporation
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 Strategic outlook
10.9.5 SWOT analysis
10.10 OBS Medical
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 SOC Telemed
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Specialist Telemed
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 Strategic outlook
10.12.5 SWOT analysis
10.13 Teladoc Health
10.13.1 Business overview
10.13.2 Financial data
10.13.3 Product landscape
10.13.4 Strategic outlook
10.13.5 SWOT analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers